Bleeding Recurrence and Mortality Following Interventional Management of Spontaneous HCC Rupture: Results of a Multicenter European Study.

Date publication

août 2017

Journal

World journal of surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AYAV Ahmet

Tous les auteurs :
Schwarz L, Bubenheim M, Zemour J, Herrero A, Muscari F, Ayav A, Riboud R, Ducerf C, Regimbeau JM, Tranchart H, Lermite E, Petrovai G, Suhol A, Doussot A, Capussotti L, Tuech JJ, Le Treut YP,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28799103

Résumé

The incidence of spontaneous rupture of hepatocellular carcinoma (HCC) is low in Europe, at less than 3%. HCC rupture remains a life-threatening complication, with mortality reported between 16 and 30%. The risk of bleeding recurrence has never been clearly evaluated in such clinical situation. The objectives of this study were to evaluate the current risk of mortality related to HCC rupture and to focus on the risk of bleeding recurrence following interventional management.

Mots clés

Adult, Aged, Carcinoma, Hepatocellular, complications, Cohort Studies, Female, Hemorrhage, etiology, Hemostatic Techniques, Hospital Mortality, Humans, Liver, surgery, Liver Cirrhosis, complications, Liver Neoplasms, complications, Male, Middle Aged, Multivariate Analysis, Prognosis, Retrospective Studies, Rupture, Spontaneous

Référence

World J Surg. 2017 Aug;: